Phase 2 Proliferative Vitreoretinopathy Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Unity Health Toronto50 enrolled2 locationsNCT05523869

Recruiting

Phase 2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

Proliferative Vitreoretinopathy

Cincinnati Eye Institute, Southwest Ohio860 enrolled1 locationNCT06541574